Evidence map›Paper›PMID 32455633›Full record

ReviewJournal of clinical medicine2020

Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology.

Fernando Estévez-López, Kathleen Mudie, Xia Wang-Steverding, Inger Johanne Bakken, Andrejs Ivanovs, Jesús Castro-Marrero, Luis Nacul, Jose Alegre, Paweł Zalewski, Joanna Słomko and 10 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05454683 (Effect of Melatonin Plus Zinc Supplementation on Fatigue, Pain, Sleep Disturbances, Anxiety and Depression, and Autonomic Dysfunction in ME/CFS), which is not on this map. Cited by 47 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05454683 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Effect of Melatonin Plus Zinc Supplementation on Fatigue, Pain, Sleep Disturbances, Anxiety and Depression, and Autonomic Dysfunction in ME/CFS: a Randomized, Double-blind, Placebo-controlled Study

TypeinterventionalSponsorLaboratorios Viñas, S.A.Ran2022 to 2024Enrolled106ConditionsChronic Fatigue Syndrome, Myalgic EncephalomyelitisArmsmelatonin plus zinc, isomaltose and magnesium stearate
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Recent research in myalgic encephalomyelitis/chronic fatigue syndrome: an evidence map.Health technology assessment (Winchester, England) · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Fernando Estévez-LópezDepartment of Child and Adolescent Psychiatry/Psychology, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.ORCID 0000-0003-2960-4142
Kathleen MudieDepartment of Clinical Research, Faculty of Infectious & Tropical Disease, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.ORCID 0000-0001-7950-8680
Xia Wang-SteverdingWarwick Medical School, University of Warwick, Coventry CV4 7HL, UK.
Inger Johanne BakkenCentre for Fertility and Health (CeFH), Norwegian Institute of Public Health, 0456 Oslo, Norway.ORCID 0000-0002-4176-8257
Andrejs IvanovsStatistics Unit, Riga Stradins University, LV-1007 Riga, Latvia.ORCID 0000-0002-7376-3776
Jesús Castro-MarreroME/CFS Unit, Division of Rheumatology, Vall d'Hebron Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-2481-3052
Luis NaculDepartment of Clinical Research, Faculty of Infectious & Tropical Disease, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.ORCID 0000-0003-1411-8088
Jose AlegreME/CFS Unit, Division of Rheumatology, Vall d'Hebron Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.ORCID 0000-0002-7582-7585
Paweł ZalewskiDepartment of Hygiene, Epidemiology, Ergonomics and Postgraduate Education, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, Poland.ORCID 0000-0001-8453-7785
Joanna SłomkoDepartment of Hygiene, Epidemiology, Ergonomics and Postgraduate Education, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, Poland.ORCID 0000-0002-8503-3172
Elin Bolle StrandFaculty of Health Studies, VID Specialized University, 0370 Oslo, Norway.
Derek PhebyFaculty of Health and Society, Buckinghamshire New University, High Wycombe HP11 3JZ, UK.ORCID 0000-0003-1726-0717
Evelina ShikovaDepartment of Virology, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria & The National Specialized Hospital for Active Treatment in Haematological Diseases, 1233 Sofia, Bulgaria.ORCID 0000-0002-4367-3518
Lorenzo LorussoNeurology Department, ASST-Lecco, 23807 Merate, Italy.ORCID 0000-0002-5894-8545
Enrica CapelliDepartment of Earth and Environmental Sciences and Centre for Health Technologies, University of Pavia, 27100 Pavia, Italy.
Slobodan SekulicDepartment of Neurology, Medical Faculty Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.ORCID 0000-0001-7889-310X
Carmen ScheibenbogenInstitute for Medical Immunology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.ORCID 0000-0002-8554-9638
Nuno SepúlvedaDepartment of Clinical Research, Faculty of Infectious & Tropical Disease, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.ORCID 0000-0002-8542-1706
Modra MurovskaInstitute of Microbiology and Virology, Riga Stradins University, LV-1007 Riga, Latvia.ORCID 0000-0003-0971-1784
Eliana LacerdaDepartment of Clinical Research, Faculty of Infectious & Tropical Disease, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.ORCID 0000-0002-5077-7868

Funding

A longitudinal immunological and virological study for ME CFS biomarker discovery (Renewal)R01AI103629 · NIAID · LONDON SCH/HYGIENE & TROPICAL MEDICINE · PI DOCKRELL, HAZEL MARGUERITE, NACUL, LUIS · 2013 to 2020
$4.1M
NIAID NIH HHS R01 AI103629
6 · The paper itself

Abstract

This review aimed at determining the prevalence and incidence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in Europe. We conducted a primary search in Scopus, PubMed and Web of Science for publications between 1994 and 15 June 2019 (PROSPERO: CRD42017078688). Additionally, we performed a backward-(reference lists) and forward-(citations) search of the works included in this review. Grey literature was addressed by contacting all members of the European Network on ME/CFS (EUROMENE). Independent reviewers searched, screened and selected studies, extracted data and evaluated the methodological and reporting quality. For prevalence, two studies in adults and one study in adolescents were included. Prevalence ranged from 0.1% to 2.2%. Two studies also included incidence estimates. In conclusion, studies on the prevalence and incidence of ME/CFS in Europe were scarce. Our findings point to the pressing need for well-designed and statistically powered epidemiological studies. To overcome the shortcomings of the current state-of-the-art, EUROMENE recommends that future research is better conducted in the community, reviewing the clinical history of potential cases, obtaining additional objective information (when needed) and using adequate ME/CFS case definitions; namely, the Centers for Disease Control & Prevention-1994, Canadian Consensus Criteria, or Institute of Medicine criteria.

Indexed as

central nervous system diseasesinfectionsmuscular diseasespost-exertional malaisevirus diseases

Identifiers

PMID32455633
PMCPMC7290765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.